SOPHiA GENETICS (NASDAQ: SOPH) officer lines up 10,000-share sale

Rhea-AI Filing Summary

SOPHiA GENETICS SA (SOPH) has a notice of proposed sale of securities filed under Rule 144 by officer Manuela Valente. The filing covers the planned sale of 10,000 shares of common stock, to be issued via exercise of stock options for cash and sold through Morgan Stanley Smith Barney LLC on NASDAQ on 08/19/2026. The notice also lists a prior Rule 10b5-1 sale of 4,241 shares of common stock on 07/06/2026.

Key Figures

Shares to be sold: 10,000 shares Aggregate value of proposed sale: $76,200.00 Planned sale date: 08/19/2026 +2 more

5 metrics

Shares to be sold 10,000 shares Common stock proposed to be sold by Manuela Valente under Rule 144

Aggregate value of proposed sale $76,200.00 Total value reported for 10,000 SOPH common shares

Planned sale date 08/19/2026 Date for proposed sale and option exercise of 10,000 shares

Shares sold in prior 3 months 4,241 shares Common shares sold on 07/06/2026 under a 10b5-1 plan

Aggregate proceeds of prior sale $21,429.77 Total amount for the 4,241 SOPH shares sold on 07/06/2026

Key Terms

Rule 144, 10b5-1, Exercise of Stock Options

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5-1 regulatory

"10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Common | 08/19/2026 | Exercise of Stock Options | Issuer"

FAQ

What does the Form 144 filing for SOPH (SOPHiA GENETICS SA) by Manuela Valente disclose?

The filing discloses that officer Manuela Valente intends to sell 10,000 shares of SOPH common stock under Rule 144, following exercise of stock options for cash, with sales arranged through Morgan Stanley Smith Barney LLC on 08/19/2026.

How many SOPH shares are proposed to be sold and at what aggregate value?

The notice covers a proposed sale of 10,000 common shares of SOPHiA GENETICS SA with an aggregate value of $76,200.00. These shares are tied to an exercise of stock options to be settled in cash before sale.

What prior sales are reported in the SOPH Form 144 for the past three months?

The filing reports that on 07/06/2026, 4,241 shares of SOPH common stock were sold for an aggregate amount of $21,429.77 under a Rule 10b5-1 trading plan for Manuela Valente.

Which broker is handling the proposed SOPH share sale under this Form 144?

The proposed sale of 10,000 SOPH common shares is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, with the shares listed for trading on NASDAQ.

How are the SOPH shares in this Form 144 being acquired before sale?

The shares are being acquired through an exercise of stock options by Manuela Valente, with the transaction described as an Exercise of Stock Options for 10,000 common shares, to be paid in cash on 08/19/2026 before resale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 04:31 PM Accepted by SEC EDGAR 08/19/2026 - 04:30 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002009280
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SOPHIA GENETICS SA
SEC File Number	001-40627
Address of Issuer	La Piece 12 ch-1180 Rolle SWITZERLAND 00000
Phone	41216941060
Name of Person for Whose Account the Securities are To Be Sold	MANUELA VALENTE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	76200.00	85127825	08/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2026	Exercise of Stock Options	Issuer			10000	08/19/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	07/06/2026	4241	21429.77

144: Remarks and Signature

Remarks
Date of Notice	08/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/03/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Manuela Valente
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)